235 related articles for article (PubMed ID: 23111009)
1. MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis.
Liang J; Liu C; Qiao A; Cui Y; Zhang H; Cui A; Zhang S; Yang Y; Xiao X; Chen Y; Fang F; Chang Y
J Hepatol; 2013 Mar; 58(3):535-42. PubMed ID: 23111009
[TBL] [Abstract][Full Text] [Related]
2. The KLF14 transcription factor regulates hepatic gluconeogenesis in mice.
Wang L; Tong X; Gu F; Zhang L; Chen W; Cheng X; Xie L; Chang Y; Zhang H
J Biol Chem; 2017 Dec; 292(52):21631-21642. PubMed ID: 29123026
[TBL] [Abstract][Full Text] [Related]
3. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice.
Zhang L; Bai M; Tang H; Zhou F; Zhu Q; Wang S; Zhu K; Liu Q; Liu Y; Wang X; Ma Y; Zhou L
Life Sci; 2019 Jan; 217():185-192. PubMed ID: 30528184
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
5. KLF10 transcription factor regulates hepatic glucose metabolism in mice.
Yang X; Chen Q; Sun L; Zhang H; Yao L; Cui X; Gao Y; Fang F; Chang Y
Diabetologia; 2017 Dec; 60(12):2443-2452. PubMed ID: 28836014
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
8. Transcriptional coactivator NT-PGC-1α promotes gluconeogenic gene expression and enhances hepatic gluconeogenesis.
Chang JS; Jun HJ; Park M
Physiol Rep; 2016 Oct; 4(20):. PubMed ID: 27798359
[TBL] [Abstract][Full Text] [Related]
9. Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver.
Haase TN; Ringholm S; Leick L; Biensø RS; Kiilerich K; Johansen S; Nielsen MM; Wojtaszewski JF; Hidalgo J; Pedersen PA; Pilegaard H
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1501-9. PubMed ID: 21832205
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G
Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116
[TBL] [Abstract][Full Text] [Related]
11. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis.
Kurano M; Hara M; Satoh H; Tsukamoto K
Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144
[TBL] [Abstract][Full Text] [Related]
12. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S
J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice.
Tamura Y; Ogihara T; Uchida T; Ikeda F; Kumashiro N; Nomiyama T; Sato F; Hirose T; Tanaka Y; Mochizuki H; Kawamori R; Watada H
Diabetologia; 2007 Jan; 50(1):131-41. PubMed ID: 17093946
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4.
Li K; Zhang J; Yu J; Liu B; Guo Y; Deng J; Chen S; Wang C; Guo F
J Biol Chem; 2015 Mar; 290(13):8185-95. PubMed ID: 25657009
[TBL] [Abstract][Full Text] [Related]
15. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
17. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
[TBL] [Abstract][Full Text] [Related]
19. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.
Wu C; Khan SA; Peng LJ; Li H; Carmella SG; Lange AJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E536-43. PubMed ID: 16621898
[TBL] [Abstract][Full Text] [Related]
20. The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.
Shlomai A; Rechtman MM; Burdelova EO; Zilberberg A; Hoffman S; Solar I; Fishman S; Halpern Z; Sklan EH
J Hepatol; 2012 Oct; 57(4):867-73. PubMed ID: 22732512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
